1. Home
  2. SB vs CERT Comparison

SB vs CERT Comparison

Compare SB & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Safe Bulkers Inc ($0.001 par value)

SB

Safe Bulkers Inc ($0.001 par value)

HOLD

Current Price

$6.41

Market Cap

682.2M

ML Signal

HOLD

CERT

Certara Inc.

HOLD

Current Price

$6.96

Market Cap

808.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
SB
CERT
Founded
2007
2008
Country
Monaco
United States
Employees
1107
N/A
Industry
Marine Transportation
Retail: Computer Software & Peripheral Equipment
Sector
Consumer Discretionary
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
682.2M
808.9M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
SB
CERT
Price
$6.41
$6.96
Analyst Decision
Strong Buy
Buy
Analyst Count
1
10
Target Price
$6.00
$11.67
AVG Volume (30 Days)
864.5K
4.8M
Earning Date
05-18-2026
05-11-2026
Dividend Yield
3.03%
N/A
EPS Growth
N/A
87.50
EPS
N/A
N/A
Revenue
N/A
$418,838,000.00
Revenue This Year
$3.47
$4.18
Revenue Next Year
$3.61
$5.39
P/E Ratio
$16.77
N/A
Revenue Growth
N/A
8.75
52 Week Low
$3.61
$4.45
52 Week High
$7.38
$13.88

Technical Indicators

Market Signals
Indicator
SB
CERT
Relative Strength Index (RSI) 44.51 71.99
Support Level $6.32 $5.93
Resistance Level $6.63 $7.52
Average True Range (ATR) 0.27 0.41
MACD -0.04 0.17
Stochastic Oscillator 23.44 96.91

Price Performance

Historical Comparison
SB
CERT

About SB Safe Bulkers Inc ($0.001 par value)

Safe Bulkers Inc is an international provider of marine drybulk transportation services, transporting bulk cargoes, particularly coal, grain, and iron ore, along international shipping routes for consumers of marine drybulk transportation services. The company employs its vessels on both period time charters and spot time charters, according to the assessment of market conditions, with consumers of marine drybulk transportation services. The company generates almost all of its revenue from Time Charters.

About CERT Certara Inc.

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.

Share on Social Networks: